Screener · short volume
Short volume screener
Screen US-listed stocks by FINRA daily short volume. Filter by market cap, sector and industry; sort by short %, short volume, total volume or market cap.
1D · FINRA Reg SHO · as of Nov 5, 2026
| # | Ticker | Company | Sector | Market cap | Short | Total | Short % |
|---|---|---|---|---|---|---|---|
| 1 | BRVE | Braveheart Bio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.57B | 848.7K | 896.2K | 94.7% |
| 2 | PBLS | Parabilis Medicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $3.40B | 278.7K | 303.3K | 91.9% |
| 3 | SYRE | Spyre Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $9.17B | 412.9K | 456.2K | 90.5% |
| 4 | AVLN | Avalyn Pharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.18B | 156.5K | 177.8K | 88.0% |
| 5 | GHRS | GH Research PLC | Health CareBiotechnology: Pharmaceutical Preparations | $1.26B | 160.0K | 183.3K | 87.3% |
| 6 | KARD | Kardigan Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.30B | 258.6K | 297.0K | 87.1% |
| 7 | OGN | Organon & Co. | Health CareBiotechnology: Pharmaceutical Preparations | $3.62B | 1.76M | 2.06M | 85.6% |
| 8 | COAG | Hemab Therapeutics Holdings Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $2.13B | 147.6K | 173.1K | 85.3% |
| 9 | ESLA | Estrella Immunopharma Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $18.0M | 105.6K | 124.3K | 85.0% |
| 10 | NVST | Envista Holdings Corporation | Health CareMedical/Dental Instruments | $4.01B | 2.07M | 2.47M | 83.9% |
| 11 | BLLN | BillionToOne Inc. | Health CareMedical Specialities | $5.30B | 664.9K | 802.5K | 82.9% |
| 12 | CGON | CG Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $5.74B | 287.1K | 348.0K | 82.5% |
| 13 | IMNM | Immunome Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.11B | 666.1K | 809.4K | 82.3% |
| 14 | AKTS | Aktis Oncology Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $825.9M | 109.2K | 134.9K | 80.9% |
| 15 | IPEX | Inflection Point Acquisition Corp. V | Health CareBiotechnology: Pharmaceutical Preparations | - | 256.7K | 317.8K | 80.8% |
| 16 | CNMD | CONMED Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $1.57B | 124.4K | 154.6K | 80.5% |
| 17 | PLX | Protalix BioTherapeutics Inc. (DE) | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $202.2M | 310.1K | 385.7K | 80.4% |
| 18 | DNTH | Dianthus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.64B | 372.0K | 467.0K | 79.7% |
| 19 | ESTA | Establishment Labs Holdings Inc. | Health CareIndustrial Specialties | $1.92B | 104.6K | 133.6K | 78.3% |
| 20 | VERA | Vera Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.17B | 456.9K | 584.7K | 78.1% |
| 21 | IMVT | Immunovant Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $5.86B | 262.8K | 337.0K | 78.0% |
| 22 | TYRA | Tyra Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.44B | 170.4K | 219.2K | 77.7% |
| 23 | NEOG | Neogen Corporation | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.55B | 1.01M | 1.31M | 77.6% |
| 24 | ORKA | Oruka Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $6.36B | 290.5K | 376.1K | 77.3% |
| 25 | PCVX | Vaxcyte Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $9.75B | 537.2K | 697.0K | 77.1% |
| 26 | INSP | Inspire Medical Systems Inc. | Health CareMedical/Dental Instruments | $1.93B | 321.0K | 416.7K | 77.0% |
| 27 | EOLS | Evolus Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $449.1M | 643.1K | 838.1K | 76.7% |
| 28 | BTMD | Biote Corp. | Health CareMedicinal Chemicals and Botanical Products | $37.4M | 134.6K | 175.9K | 76.5% |
| 29 | JBIO | Jade Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $896.7M | 332.2K | 437.0K | 76.0% |
| 30 | ZBIO | Zenas BioPharma Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.69B | 301.1K | 396.4K | 76.0% |
| 31 | KMTS | Kestra Medical Technologies Ltd. | Health CareMedical/Dental Instruments | $1.70B | 191.9K | 253.2K | 75.8% |
| 32 | KALV | KalVista Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | - | 366.4K | 485.4K | 75.5% |
| 33 | LKFT | Lakefront Biotherapeutics | Health CareBiotechnology: Pharmaceutical Preparations | $2.21B | 82.1K | 108.8K | 75.4% |
| 34 | ERAS | Erasca Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $4.64B | 1.77M | 2.34M | 75.4% |
| 35 | ANRO | Alto Neuroscience Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $858.2M | 82.8K | 109.9K | 75.4% |
| 36 | ATTO | Attovia Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $684.8M | 90.2K | 119.9K | 75.2% |
| 37 | RCUS | Arcus Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $2.25B | 658.8K | 876.8K | 75.1% |
| 38 | BDTX | Black Diamond Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $95.4M | 181.5K | 241.7K | 75.1% |
| 39 | ANVS | Annovis Bio Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $28.6M | 17.24M | 23.02M | 74.9% |
| 40 | GNLX | Genelux Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $82.3M | 80.1K | 107.1K | 74.8% |
| 41 | STTK | Shattuck Labs Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $450.6M | 388.9K | 520.7K | 74.7% |
| 42 | AKBA | Akebia Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $120.0M | 8.58M | 11.53M | 74.4% |
| 43 | OLMA | Olema Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $591.5M | 561.2K | 758.8K | 74.0% |
| 44 | LENZ | LENZ Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $94.6M | 196.4K | 266.2K | 73.8% |
| 45 | ALGN | Align Technology Inc. | Health CareIndustrial Specialties | $11.32B | 409.2K | 555.4K | 73.7% |
| 46 | RIGL | Rigel Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $853.9M | 164.4K | 223.4K | 73.6% |
| 47 | FOLD | Amicus Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | - | 1.18M | 1.61M | 73.2% |
| 48 | FTRE | Fortrea Holdings Inc. | Health CareMedical Specialities | $1.97B | 716.1K | 980.9K | 73.0% |
| 49 | NUS | Nu Skin Enterprises Inc. | Health CareOther Pharmaceuticals | $220.5M | 170.0K | 233.7K | 72.8% |
| 50 | TARS | Tarsus Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $3.33B | 221.9K | 306.2K | 72.5% |
| 51 | GENB | Generate Biomedicines Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.61B | 296.5K | 409.4K | 72.4% |
| 52 | USPH | U.S. Physical Therapy Inc. | Health CareMedical/Nursing Services | $1.45B | 88.5K | 122.5K | 72.2% |
| 53 | GLSI | Greenwich LifeSciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $215.0M | 72.9K | 101.0K | 72.2% |
| 54 | UHS | Universal Health Services Inc. | Health CareHospital/Nursing Management | $11.70B | 367.0K | 509.5K | 72.0% |
| 55 | SCTX | Scribe Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $293.1M | 85.4K | 118.8K | 71.9% |
| 56 | CRDF | Cardiff Oncology Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $59.0M | 271.6K | 378.3K | 71.8% |
| 57 | BVS | Bioventus Inc. | Health CareMedical/Dental Instruments | $899.9M | 218.3K | 304.5K | 71.7% |
| 58 | EPRX | Eupraxia Pharmaceuticals Inc. | Health CarePharmaceuticals and Biotechnology | $435.0M | 254.5K | 355.1K | 71.7% |
| 59 | CRBU | Caribou Biosciences Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $44.4M | 636.1K | 890.9K | 71.4% |
| 60 | ACRV | Acrivon Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $67.3M | 104.6K | 146.9K | 71.2% |
| 61 | BBTX | Bambusa Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $640.1M | 107.0K | 150.4K | 71.1% |
| 62 | MGTX | MeiraGTx Holdings plc | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $817.3M | 154.4K | 217.4K | 71.0% |
| 63 | CERS | Cerus Corporation | Health CareMedical/Dental Instruments | $429.3M | 840.9K | 1.19M | 70.6% |
| 64 | MMSI | Merit Medical Systems Inc. | Health CareMedical/Dental Instruments | $5.37B | 291.4K | 412.8K | 70.6% |
| 65 | PTGX | Protagonist Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.75B | 134.5K | 190.8K | 70.5% |
| 66 | ORGO | Organogenesis Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $108.1M | 174.3K | 247.3K | 70.5% |
| 67 | ADCT | ADC Therapeutics SA | Health CareBiotechnology: Pharmaceutical Preparations | $209.4M | 578.1K | 820.3K | 70.5% |
| 68 | BTSG | BrightSpring Health Services Inc. | Health CareMedical/Nursing Services | $13.11B | 989.4K | 1.40M | 70.5% |
| 69 | ODTX | Odyssey Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $907.3M | 105.3K | 150.0K | 70.2% |
| 70 | DGX | Quest Diagnostics Incorporated | Health CareMedical Specialities | $28.03B | 242.4K | 345.8K | 70.1% |
| 71 | LGND | Ligand Pharmaceuticals Incorporated | Health CareBiotechnology: Pharmaceutical Preparations | $5.98B | 72.9K | 104.1K | 70.1% |
| 72 | IKT | Inhibikase Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $200.3M | 173.8K | 249.1K | 69.8% |
| 73 | ASMB | Assembly Biosciences Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $407.2M | 119.1K | 170.8K | 69.7% |
| 74 | GERN | Geron Corporation | Health CareBiotechnology: Pharmaceutical Preparations | $610.3M | 11.24M | 16.12M | 69.7% |
| 75 | ABEO | Abeona Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $223.6M | 509.3K | 735.5K | 69.2% |
| 76 | CNTN | Canton Strategic Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $153.8M | 182.9K | 264.4K | 69.2% |
| 77 | RMD | ResMed Inc. | Health CareMedical/Dental Instruments | $33.66B | 441.4K | 638.2K | 69.2% |
| 78 | NAGE | Niagen Bioscience Inc. | Health CareMedicinal Chemicals and Botanical Products | $167.0M | 432.5K | 627.5K | 68.9% |
| 79 | XFOR | X4 Pharmaceuticals Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $304.4M | 164.0K | 238.3K | 68.8% |
| 80 | CLDX | Celldex Therapeutics Inc. | Health CareBiotechnology: In Vitro & In Vivo Diagnostic Substances | $2.22B | 292.4K | 425.5K | 68.7% |
| 81 | PMVP | PMV Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $95.5M | 216.2K | 315.8K | 68.5% |
| 82 | BMRN | BioMarin Pharmaceutical Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $10.87B | 490.5K | 721.6K | 68.0% |
| 83 | ASND | Ascendis Pharma A/S | Health CareBiotechnology: Pharmaceutical Preparations | $16.70B | 168.9K | 249.0K | 67.8% |
| 84 | ARWR | Arrowhead Pharmaceuticals Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $8.12B | 479.6K | 709.3K | 67.6% |
| 85 | MASI | Masimo Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | - | 326.1K | 483.2K | 67.5% |
| 86 | IART | Integra LifeSciences Holdings Corporation | Health CareMedical/Dental Instruments | $1.10B | 212.8K | 315.3K | 67.5% |
| 87 | HRMY | Harmony Biosciences Holdings Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $1.89B | 352.1K | 521.9K | 67.5% |
| 88 | XOMA | XOMA Royalty Corporation | Health CareBiotechnology: Pharmaceutical Preparations | - | 768.4K | 1.14M | 67.4% |
| 89 | ITGR | Integer Holdings Corporation | Health CareBiotechnology: Electromedical & Electrotherapeutic Apparatus | $4.31B | 170.6K | 253.2K | 67.4% |
| 90 | ELTX | Elicio Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $37.9M | 88.3K | 131.2K | 67.3% |
| 91 | DSGN | Design Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $605.2M | 103.5K | 153.8K | 67.3% |
| 92 | DWTX | Dogwood Therapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $39.8M | 76.5K | 113.7K | 67.2% |
| 93 | GMED | Globus Medical Inc. | Health CareMedical/Dental Instruments | $10.93B | 1.04M | 1.55M | 67.1% |
| 94 | BTI | British American Tobacco Industries p.l.c. | Health CareMedicinal Chemicals and Botanical Products | $136.27B | 2.21M | 3.30M | 67.0% |
| 95 | BAX | Baxter International Inc. | Health CareMedical/Dental Instruments | $13.27B | 2.35M | 3.51M | 66.9% |
| 96 | TNYA | Tenaya Therapeutics Inc. | Health CareBiotechnology: Biological Products (No Diagnostic Substances) | $72.9M | 3.30M | 4.94M | 66.8% |
| 97 | LTGO | Latigo Biotherapeutics Inc. | Health CareBiotechnology: Pharmaceutical Preparations | $862.6M | 101.0K | 151.3K | 66.8% |
| 98 | DXCM | DexCom Inc. | Health CareMedical/Dental Instruments | $31.50B | 1.05M | 1.58M | 66.7% |
| 99 | TRUP | Trupanion Inc. | Health CareMedical Specialities | $1.52B | 185.0K | 277.3K | 66.7% |
| 100 | BKD | Brookdale Senior Living Inc. | Health CareHospital/Nursing Management | $2.58B | 2.43M | 3.64M | 66.7% |